Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator
Background The early-onset sepsis (EOS) calculator was developed and validated in a setting with routine-based group B Streptococcus (GBS) screening. Purpose The study aimed to evaluate the extent of influence exerted by risk-based GBS screening on management recommendations by the EOS calculator. M...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Pediatric Society
2020-10-01
|
Series: | Clinical and Experimental Pediatrics |
Subjects: | |
Online Access: | http://www.e-cep.org/upload/pdf/cep-2020-00094.pdf |
id |
doaj-7d6b9245469546939967f45dc353dc2f |
---|---|
record_format |
Article |
spelling |
doaj-7d6b9245469546939967f45dc353dc2f2020-11-25T04:08:56ZengThe Korean Pediatric SocietyClinical and Experimental Pediatrics2713-41482020-10-01631040641010.3345/cep.2020.0009420125553641Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculatorNiek B. Achten0J. Wendelien Dorigo-Zetsma1Annemarie M.C. van Rossum2Rianne Oostenbrink3Frans B. Plötz4 Department of Paediatrics, Tergooi Hospitals, Blaricum, The Netherlands Department of Microbiology, Tergooi Hospitals, Blaricum, The Netherlands Division of Infectious Diseases and Immunology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands Department of General Pediatrics, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands Department of Paediatrics, Tergooi Hospitals, Blaricum, The NetherlandsBackground The early-onset sepsis (EOS) calculator was developed and validated in a setting with routine-based group B Streptococcus (GBS) screening. Purpose The study aimed to evaluate the extent of influence exerted by risk-based GBS screening on management recommendations by the EOS calculator. Methods All newborns with a gestational age greater than 35 weeks were screened for EOS risk factors in a Dutch regional teaching hospital using a risk-based GBS screening strategy. We calculated the EOS risk at birth and stratified the infants into the following 3 risk levels with corresponding management recommendations: low, <0.65; intermediate, 0.65–1.54; and high, >1.54 per 1000 live newborns. Thereafter, we recalculated the EOS risk and recommendation for the newborn infants without available maternal GBS screening results at birth. Results In one year, 1,877 eligible births occurred; of them, 206 infants were included. Maternal GBS status was available for 28 of 206 infants (14%) at birth, while a definitive GBS status was later available for 162 of 206 infants (79%). Median EOS risk was slightly lower after definitive GBS status was determined (0.41 vs. 0.46 per 1,000 live births, P=0.004). In 199 of 206 newborn infants (97%), the EOS calculator recommendation remained unchanged after the GBS results unavailable at birth were updated to definitive GBS status. Use of GBS status at birth versus definitive GBS status did not result in the withholding of antibiotic treatment of the newborn infants included in this study. Conclusion Risk-based GBS screening is compatible with EOS calculator recommendations. Larger studies are needed to develop the best strategy for combining GBS screening and EOS calculator recommendations.http://www.e-cep.org/upload/pdf/cep-2020-00094.pdfearly-onset sepsisgroup b maternal screeningneonatalsepsis calculator |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niek B. Achten J. Wendelien Dorigo-Zetsma Annemarie M.C. van Rossum Rianne Oostenbrink Frans B. Plötz |
spellingShingle |
Niek B. Achten J. Wendelien Dorigo-Zetsma Annemarie M.C. van Rossum Rianne Oostenbrink Frans B. Plötz Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator Clinical and Experimental Pediatrics early-onset sepsis group b maternal screening neonatal sepsis calculator |
author_facet |
Niek B. Achten J. Wendelien Dorigo-Zetsma Annemarie M.C. van Rossum Rianne Oostenbrink Frans B. Plötz |
author_sort |
Niek B. Achten |
title |
Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
title_short |
Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
title_full |
Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
title_fullStr |
Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
title_full_unstemmed |
Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
title_sort |
risk-based maternal group b streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator |
publisher |
The Korean Pediatric Society |
series |
Clinical and Experimental Pediatrics |
issn |
2713-4148 |
publishDate |
2020-10-01 |
description |
Background The early-onset sepsis (EOS) calculator was developed and validated in a setting with routine-based group B Streptococcus (GBS) screening. Purpose The study aimed to evaluate the extent of influence exerted by risk-based GBS screening on management recommendations by the EOS calculator. Methods All newborns with a gestational age greater than 35 weeks were screened for EOS risk factors in a Dutch regional teaching hospital using a risk-based GBS screening strategy. We calculated the EOS risk at birth and stratified the infants into the following 3 risk levels with corresponding management recommendations: low, <0.65; intermediate, 0.65–1.54; and high, >1.54 per 1000 live newborns. Thereafter, we recalculated the EOS risk and recommendation for the newborn infants without available maternal GBS screening results at birth. Results In one year, 1,877 eligible births occurred; of them, 206 infants were included. Maternal GBS status was available for 28 of 206 infants (14%) at birth, while a definitive GBS status was later available for 162 of 206 infants (79%). Median EOS risk was slightly lower after definitive GBS status was determined (0.41 vs. 0.46 per 1,000 live births, P=0.004). In 199 of 206 newborn infants (97%), the EOS calculator recommendation remained unchanged after the GBS results unavailable at birth were updated to definitive GBS status. Use of GBS status at birth versus definitive GBS status did not result in the withholding of antibiotic treatment of the newborn infants included in this study. Conclusion Risk-based GBS screening is compatible with EOS calculator recommendations. Larger studies are needed to develop the best strategy for combining GBS screening and EOS calculator recommendations. |
topic |
early-onset sepsis group b maternal screening neonatal sepsis calculator |
url |
http://www.e-cep.org/upload/pdf/cep-2020-00094.pdf |
work_keys_str_mv |
AT niekbachten riskbasedmaternalgroupbstreptococcusscreeningstrategyiscompatiblewiththeimplementationofneonatalearlyonsetsepsiscalculator AT jwendeliendorigozetsma riskbasedmaternalgroupbstreptococcusscreeningstrategyiscompatiblewiththeimplementationofneonatalearlyonsetsepsiscalculator AT annemariemcvanrossum riskbasedmaternalgroupbstreptococcusscreeningstrategyiscompatiblewiththeimplementationofneonatalearlyonsetsepsiscalculator AT rianneoostenbrink riskbasedmaternalgroupbstreptococcusscreeningstrategyiscompatiblewiththeimplementationofneonatalearlyonsetsepsiscalculator AT fransbplotz riskbasedmaternalgroupbstreptococcusscreeningstrategyiscompatiblewiththeimplementationofneonatalearlyonsetsepsiscalculator |
_version_ |
1724424004276584448 |